Cary, N.C.-based Myco Medical has won a private-label contract deal with Novation, according to a Triangle Business Journal report.
Supply Chain
The global market for medical transcription services is expected to reach $60.6 million by 2019, according to a news release from Transparency Market Research.
The U.S. Food and Drug Administration has issued a Class I Recall on Spacelabs Healthcare's BleaseSirius and BleaseFocus Anesthesia Workstations due to loose hardware in the CAS I/II Absorbers, which could cause the Bag-to-Vent switch to fail.
Pomona, Calif.-based CLR Medicals International has issued a nationwide recall on its Viscocel and Viscocel Plus products.
Janssen Therapeutics, a division of Janssen Products, announced that the U.S. Food and Drug Administration approved OLYSIO (simeprevir), an NS3/4A protease inhibitor.
Advertisement
The U.S. Food and Drug Administration issued a warning letter to 23andMe to stop marketing and selling the company's Saliva Collection Kit and Personal Genome Service, saying the PGS had not received approval from the FDA.
Mansfield, Mass.-based Covidien plans to open an $18 million production facility in Hillsborough County, Fla., according to a Plastics News report.
MediPurpose, a Singapore-based medical device manufacturer and distributor, has entered a private label deal with EKF Diagnostics for MediPurpose's SurgiLance safety lancet, according to a MediPurpose news release.
IbisWorld, a business industry research firm, projects the medical instrument and supply manufacturing industry will continue to grow at a steady pace for the next five years.
OrthAlign, a privately held medical device company, announced it has received 510(k) clearance from the United States Food and Drug Administration to market its ORTHALIGN PLUS system.